Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Iproceedings

Date Submitted: Jan 28, 2022
Date Accepted: Jan 28, 2022

The final, peer-reviewed published version of this preprint can be found here:

Digital Dermatology: Experience From Scotland During Lockdown and Beyond

Muthiah S, Morton CA

Digital Dermatology: Experience From Scotland During Lockdown and Beyond

Iproc 2022;8(1):e36884

DOI: 10.2196/36884

Digital Dermatology - Experience from Scotland During Lockdown and Beyond

  • Shareen Muthiah; 
  • Colin, A Morton

ABSTRACT

Background:

In Scotland, dermatology outpatient services deliver over 300,000 appointments each year. With a significant growth in both new and return attendances, there is an increasing drive for innovative transformation. In response to this challenge, a Digital Dermatology Asynchronous (DDA) consultation platform was co-developed with two NHS Dermatology teams. Roll-out of the platform was accelerated during Scotland’s initial COVID-19 lockdown and its wider scope prospectively evaluated.

Objective:

The aims of the platform were: 1. To improve the patient experience by reducing the need to attend hospital for consultations. 2. To modernise delivery of outpatient care, providing clinicians with a store-and-forward form of telemedicine. 3. To use an integrated digital platform, linking with booking systems and the electronic patient record, to increase efficiency and capacity thereby creating a more sustainable outpatient service. 4. To create a positive environmental impact by reducing travel and hence carbon footprint.

Methods:

During an 11-week ‘lockdown’ period from late March 2020, 405 consultations were prospectively audited. Clinicians were asked to complete data collection proformas for each consultation detailing patient demographics, quality of images, diagnosis and outcomes. The time taken to complete each virtual consultation was recorded for 312 consultations. Feedback surveys were completed by patients and clinicians via email.

Results:

Of the 405 consultations, 297 new and 108 return patient consultations were assessed, with 80% of images submitted of satisfactory quality. 292 consultations involved the assessment of lesions, with most referred as suspected cancers. Patients of all ages participated with 31% over the age of 60, as well as parents of 12 children. The consultations were on average 3 minutes shorter than equivalent face-to-face (F2F) interactions and a total of 5758km of patient travel was avoided. Outcomes included virtual review (16%), F2F review (47%), direct to surgery (11%), discharge (22%) and other treatment/investigation (4%). The majority of those needing F2F review were scheduled for routine follow-up. Patient satisfaction was high, with 82% of respondents reporting ease of use.

Conclusions:

The COVID-19 pandemic has resulted in a paradigm shift in the way we deliver out-patient care. DDA consultations are now operational in four health boards and have been successfully included in the choice of consultation type available for patients, helping to augment service capacity during pandemic recovery. The platform is the first of its kind in Scotland to be integrated with the hospital booking system and electronic patient record, offering a valuable alternative to F2F, telephone and video consultations.


 Citation

Please cite as:

Muthiah S, Morton CA

Digital Dermatology: Experience From Scotland During Lockdown and Beyond

Iproc 2022;8(1):e36884

DOI: 10.2196/36884

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.